AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Snipd AI
Discover the booming market of weight-loss drugs with companies like Novo Nordisk and Eli Lilly dominating. The competition is fierce as new players enter the scene, aiming to target more patients. Learn about the development of innovative drugs like Wigovi and CT388, with forecasts predicting a billion-dollar market by 2033. Explore how increased competition could lead to better solutions, affordability, and global accessibility for millions.
Read more
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Novo Nordisk and Eli Lilly lead the weight-loss drug market with medications like Ozempic and Wegovi.
- Competition in the pharmaceutical industry is driving innovation and affordability in weight loss treatments.
Deep dives
The Rise of Novel Diabetes Medicines
Novel diabetes medicines like Ozempic and its weight loss spin-off drug, Wegovi, have garnered significant attention for not only controlling blood sugar but also inducing weight loss. The pharmaceutical company Novo Nordisk has seen immense success with these drugs, becoming Europe's most valuable company. Competitors, such as Eli Lilly, are also entering the market with similar offerings, creating a race for market dominance.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode